Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin.
Autor: | Flydal MI; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Alcorlo-Pagés M; Department of Crystallography and Structural Biology, Instituto de Química-Física 'Rocasolano,' Consejo Superior de Investigaciones Científicas (CSIC), 28006 Madrid, Spain., Johannessen FG; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Martínez-Caballero S; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Skjærven L; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Fernandez-Leiro R; Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain., Martinez A; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway; aurora.martinez@uib.no xjuan@iqfr.csic.es., Hermoso JA; Department of Crystallography and Structural Biology, Instituto de Química-Física 'Rocasolano,' Consejo Superior de Investigaciones Científicas (CSIC), 28006 Madrid, Spain; aurora.martinez@uib.no xjuan@iqfr.csic.es. |
---|---|
Jazyk: | angličtina |
Zdroj: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Jun 04; Vol. 116 (23), pp. 11229-11234. Date of Electronic Publication: 2019 May 22. |
DOI: | 10.1073/pnas.1902639116 |
Abstrakt: | Phenylalanine hydroxylase (PAH) is a key enzyme in the catabolism of phenylalanine, and mutations in this enzyme cause phenylketonuria (PKU), a genetic disorder that leads to brain damage and mental retardation if untreated. Some patients benefit from supplementation with a synthetic formulation of the cofactor tetrahydrobiopterin (BH Competing Interests: The authors declare no conflict of interest. |
Databáze: | MEDLINE |
Externí odkaz: |